Drug Trial Radar · NCT06794996
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities
Last checked: Nov 19, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Feb 4, 2025
Primary completion
Jul 20, 2026
Study completion Jul 20, 2026
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Jan 27, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 67 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated kidney disease (AMKD).
Conditions
- Proteinuric Kidney Disease
Interventions
InaxaplinDrug
Tablets for Oral Administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change in Urine Albumin-Creatinine Ratio (UACR)Time frame: Baseline and At Week 13
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Nephrology Consultants, LLC
Huntsville, Alabama
Foundation for Sickle Cell Disease Research, LLC
Hollywood, Florida
South Florida Research Institute
Lauderdale Lakes, Florida
Schiff Center for Liver Diseases
Miami, Florida
CTR Oakwater, LLC
Orlando, Florida
Renal Associates, LLC
Columbus, Georgia
Georgia Nephrology - Decatur
Decatur, Georgia
Javara Inc./Privia Medical Group Georgia, LLC - Fayetteville
Fayetteville, Georgia
Georgia Nephrology
Lawrenceville, Georgia
Javara Inc. /Privia Medical Group Georgia, LLC - Savannah
Savannah, Georgia
Renal Associates of Baton Rouge
Baton Rouge, Louisiana
LCMC Health
Metairie, Louisiana
Ochsner Medical Center - New Orleans - Nephrology
New Orleans, Louisiana
Northwest Louisiana Nephrology, LLC - Shreveport
Shreveport, Louisiana
Javara Inc./Privia Medical Group, LLC MidAtlantic-Silver Spring, MD
Silver Spring, Maryland
Nephrology Associates, P.C.
Columbus, Mississippi
Nephrology and Hypertension Associates, LTD
Tupelo, Mississippi
DaVita Kidney Care - Las Vegas
Las Vegas, Nevada
Saint Michael's Medical Center - Peter Ho Memorial Clinic
Newark, New Jersey
Rutgers Doctors Office Center
Newark, New Jersey
Scott Research, Inc.
Laurelton, New York
NYC Health + Hospital/Harlem
New York, New York
North Carolina Nephrology P.A. - Cary Office
Cary, North Carolina
UNC Clinical and Translational Research Center
Chapel Hill, North Carolina
Duke University Hospital - Children's Health Center
Durham, North Carolina
Eastern Nephrology Associates - New Bern Office
New Bern, North Carolina
Lewis Katz School of Medicine at Temple University - Section of Nephrology
Philadelphia, Pennsylvania
Columbia Nephrology Associates, PA
Columbia, South Carolina
Carolina Nephrology, PA
Spartanburg, South Carolina
Dallas Renal Group - 2
Dallas, Texas
Dallas Renal Group - 1
Dallas, Texas
Dallas Nephrology Associates - Dallas Landry Office
Dallas, Texas
UTSW Medical Center - Nephrology
Dallas, Texas
Prolato Clinical Research Center
Houston, Texas
Tks Research, P.L.L.C.
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.